?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

Archives: Resources

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
December 20, 2022 signalgroup
Shared Savings Programs in Europe
October 4, 2022 signalgroup
Inflation Reduction Act – ASP+8 Biosimilars Payment Increase
September 26, 2022 signalgroup
Biosimilars: Non-Medical Switching and Transitioning
August 3, 2022 signalgroup
Humira® Biosimilars: Reaching the Market’s Cost-Savings Potential
June 6, 2022 signalgroup
Biosimilars 101 Webinar Case Study
June 1, 2022 signalgroup
Biosimilars Forum Comments on PBM Business Practices
April 25, 2022 signalgroup
Saving Billions on Healthcare Costs with Biosimilars
April 13, 2022 signalgroup
Biosimilars Basics
September 15, 2021 signalgroup
Separate Codes and Payment for Biosimilars
June 14, 2021 signalgroup
Biosimilars Have Significantly Lowered Prices of All Biologics
  • 01
  • 02
  • 03
  • 04

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2023 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us